1,901
Views
8
CrossRef citations to date
0
Altmetric
Reviews; Medical Biotechnology

Digital image analysis in liver fibrosis: basic requirements and clinical implementation

, &
Pages 653-660 | Received 31 Jan 2016, Accepted 20 Apr 2016, Published online: 12 May 2016

References

  • Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655–1669.
  • Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614–2618.
  • Gonzalez RC, Woods RE. Digital image processing. 2nd ed. Upper Saddle River (NJ): Prentice Hall Prentice Hall; 2002.
  • Banks S. Signal processing, image processing and pattern recognition. Englewood Cliffs (NJ): Prentice-Hall; 1990.
  • Yegin EG, Yegin K, Karatay E, et al. Quantitative assessment of liver fibrosis by digital image analysis: relationship to Ishak staging and elasticity by shear-wave elastography. J Dig Dis. 2015; 16:217–227.
  • Calvaruso V, Burroughs AK, Standish R, et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology. 2009;49:1236–1244.
  • Huang Y, de Boer WB, Adams LA, et al. Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome. Liver Int. 2013;33:1249–1256.
  • Manousou P, Burroughs AK, Tsochatzis E, et al. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation. J Hepatol. 2013;58:962–968.
  • Goodman ZD, Becker RL, Pockros PJ, et al. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology. 2007;45:886–894.
  • Fontana RJ, Goodman ZD, Dienstag JL, et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology. 2008;47:1–10.
  • Xu S, Wang Y, Tai DC, et al. qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol. 2014;61:260–269.
  • Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39:239–244.
  • Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–1457.
  • Campos CF, Paiva DD, Perazzo H, et al. An inexpensive and worldwide available digital image analysis technique for histological fibrosis quantification in chronic hepatitis C. J Viral Hepat. 2014;21:216–222.
  • Lazzarini AL, Levine RA, Ploutz-Snyder RJ, et al. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int. 2005;25:1142–1149.
  • Standish RA, Cholongitas E, Dhillon A, et al. An appraisal of the histopathological assessment of liver fibrosis. Gut. 2006;55:569–578.
  • Arthur MJP. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology. 2002; 122:1525–1528.
  • Arif A, Levine RA, Sanderson SO, et al. Regression of fibrosis in virological nonresponders with chronic hepatitis C after therapy with interferon and ribavirin. Dig Dis Sci. 2003;48:1425–1430.
  • Caballero T, Perez-Milena A, Masseroli M, et al. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J Hepatol. 2001;34:740–747.
  • Manabe N, Chevallier M, Chossegros P, et al. Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. Hepatology. 1993;18:1344–1349.
  • D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231.
  • Hytiroglou P, Snover DC, Alves V, et al. Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group. Am J Clin Pathol. 2012;137:5–9.
  • Garcia-Tsao G, Friedman S, Iredale J, et al. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445–1449.
  • Tsochatzis E, Bruno S, Isgro G, et al. Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis. J Hepatol. 2014;60:948–954.
  • Sethasine S, Jain D, Groszmann RJ, et al. Quantitative histological hemodynamic correlations in cirrhosis. Hepatology. 2012;55:1146–1153.
  • Viola A, Jain D, Garcia-Tsao G. 233 Quantitative histological assessment in cirrhosis: septal thickness predicts clinical decompensation [ abstract]. J Hepatol. 2009;50:S94.
  • Kutami, R, Girgrah, N, Wanless, IR, et al. The Laennec grading system for assessment of hepatic fibrosis: validation by correlation with wedged hepatic vein pressure and clinical features [abstract]. Hepatology. 2000;32:407A.
  • Calvaruso V, Dhillon AP, Tsochatzis E, et al. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation. J Gastroenterol Hepatol. 2012;27:1227–1232.